TRIM22 and Alzheimer disease: Thus, we propose a potential mechanism of MAPK-type AD in which the TFs PPARA, RELA, and TRIM22 regulate their respective target genes AKR1A3, NFKBIA, and TBXAS1, ultimately regulating MAPK and other signaling pathways (Figure 3D).